Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 1553691

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1553691

Chemotherapy-induced Alopecia Treatment Device Market Size, Share & Trends Analysis Report By Product (Manual Cooling Systems, Automated Cooling Systems), By Sales Modality, By Indication, By End-use, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Chemotherapy-induced Alopecia Treatment Device Market Growth & Trends:

The global chemotherapy induced alopecia treatment device market size is anticipated to reach USD 174.7 million by 2030 and is projected to grow at a CAGR of 14.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market are increasing chemotherapy adoption, technological advancements, growing awareness & adoption, and government initiatives. In 2024, the American Cancer Society forecasts around 67,880 new cases of uterine cancer in the United States, with approximately 13,250 women expected to die from the disease. This significant number of cases highlights an ongoing need for effective treatment options, including chemotherapy-induced alopecia (CIA) treatment devices. As many of these patients undergo chemotherapy, there will be an increased demand for solutions that address hair loss, underscoring the importance of CIA treatment devices in supporting women through their cancer treatment journey

Advancements in chemotherapy-induced alopecia (CIA) treatment devices are driving the market growth. According to NCBI article published in March 2024, Cold capping, a non-pharmacologic approach to reducing chemotherapy-induced alopecia (CIA), is gaining recognition for its potential to preserve hair during treatment. A study reviewing the real-world effectiveness and tolerability of a manual cold capping system across diverse patient demographics found that 95% of the 100 patients who initiated cold capping completed the process. The median hair retention was reported at 75%, with 92.1% of patients achieving favorable results, defined as retaining 50% or more of their hair.

Chemotherapy-induced Alopecia Treatment Device Market Report Highlights:

  • The manual cooling systems segment led the market with the largest revenue share of 52.7% in 2023, due to ongoing product advancements, growing initiatives by key companies, and increasing cancer prevalence
  • Based on sales modality, the rental sales segment led the market with the largest revenue share of 80.9% in 2023. Growing patient awareness of scalp cooling systems has increased demand for rental options. As more individuals seek to mitigate chemotherapy-induced hair loss, healthcare providers are expanding their services to include rental programs, enhancing accessibility
  • Based on indication, the breast cancer segment led the market with the largest revenue share of 66.9% in 2023. Rising incidence of breast cancer, technological advancement, and growing awareness drive the market growth
  • Based on end use, the hospital segment led the market with the largest revenue share at 44.8% in 2023. Hospitals are integrating these CIA devices into their oncology departments to offer patients a proven method for mitigating chemotherapy-related hair loss
  • North America dominated the market with the largest revenue share of 52.8% in 2023. Rising cancer cases, product launches, regulatory approvals, and advanced healthcare infrastructure drive North America's demand for CIA treatment devices
Show more
Product Code: GVR-4-68040-433-6

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Sales Modality
    • 1.2.3. Indication
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Segment
    • 2.2.2. Sales Modality Segment
    • 2.2.3. Indication Segment
    • 2.2.4. End Use Segment
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Chemotherapy Induced Alopecia (CIA) Treatment Device Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of cancer
      • 3.2.1.2. Increasing prevalence of chemotherapy-induced alopecia
      • 3.2.1.3. Technological advancements
      • 3.2.1.4. Growing Awareness and Adoption
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Low product awareness
      • 3.2.2.2. Limited number of manufacturers
  • 3.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Product Estimates & Trend Analysis

  • 4.1. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Product Dashboard
  • 4.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Product Movement Analysis
  • 4.3. Chemotherapy Induced Alopecia (CIA) Treatment Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Manual Cooling Systems
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Automated Cooling Systems
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Sales Modality Estimates & Trend Analysis

  • 5.1. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Sales Modality Dashboard
  • 5.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Sales Modality Movement Analysis
  • 5.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Size & Forecasts and Trend Analysis, by Sales Modality, 2018 to 2030 (USD Million)
  • 5.4. Rental Sales
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Direct Sales
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Indication Estimates & Trend Analysis

  • 6.1. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Indication Dashboard
  • 6.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Indication Movement Analysis
  • 6.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 6.4. Breast Cancer
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Prostate Cancer
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Ovarian Cancer
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.7. Uterine Cancer
    • 6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: End Use Estimates & Trend Analysis

  • 7.1. Chemotherapy Induced Alopecia (CIA) Treatment Device market: End Use Dashboard
  • 7.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: End Use Movement Analysis
  • 7.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5. Cancer Centers
    • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.6. Outpatient Clinics
    • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Regional Estimates & Trend Analysis by Country, Product, Indication, Sales Modality, & End Use

  • 8.1. Global Chemotherapy induced alopecia (CIA) treatment device market: Regional Dashboard
  • 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Regulatory framework/ reimbursement structure
      • 8.3.4.3. Competitive scenario
      • 8.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.8. Norway
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.9. Denmark
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Regulatory framework/ reimbursement structure
      • 8.4.9.3. Competitive scenario
      • 8.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework/ reimbursement structure
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.3. South Africa
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
    • 9.3.4. Dignitana
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Paxman
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Penguin Cold Caps
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Chemotherapy Cold Caps, Inc.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Aspen Systems, LLC's
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Cooler Heads Care, Inc.
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Arctic Cold Caps, LLC
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Stemtech Medical Devices
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Polar Cold Caps LLC
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-433-6

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 5 Global Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 6 Global Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030
  • Table 7 Global Chemotherapy induced alopecia (CIA) treatment device market, by region, 2018 - 2030 (USD Million)
  • Table 8 North America Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 11 North America Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 12 North America Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 15 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 16 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 18 Canada Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 19 Canada Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 20 Canada Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 22 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 23 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 24 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 26 Europe Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 27 Europe Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 28 Europe Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Europe Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 UK Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 31 UK Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 32 UK Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 33 UK Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Germany Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 35 Germany Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 36 Germany Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 37 Germany Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 France Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 39 France Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 40 France Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 41 France Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 43 Italy Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 44 Italy Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 45 Italy Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 47 Spain Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 48 Spain Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 49 Spain Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 51 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 52 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 53 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 55 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 56 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 57 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Norway Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 59 Norway Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 60 Norway Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 61 Norway Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Japan Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 68 Japan Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 69 Japan Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 70 Japan Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 China Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 72 China Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 73 China Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 74 China Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 India Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 76 India Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 77 India Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 78 India Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 Australia Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 80 Australia Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 81 Australia Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 82 Australia Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 83 Australia Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 84 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 85 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 86 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 87 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 88 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 89 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 90 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 91 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 93 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 94 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 95 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 96 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 97 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 98 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 99 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 100 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 101 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 102 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 103 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 104 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 105 MEA Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 106 MEA Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 107 MEA Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 108 MEA Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 109 MEA Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 110 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 111 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 112 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 113 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 117 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 118 UAE Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 119 UAE Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 120 UAE Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 121 UAE Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 125 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 126 Participant's overview
  • Table 127 Financial performance
  • Table 128 Key companies undergoing expansions
  • Table 129 Key companies undergoing acquisitions
  • Table 130 Key companies undergoing collaborations
  • Table 131 Key companies launching new products
  • Table 132 Key companies undergoing partnerships
  • Table 133 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Chemotherapy induced alopecia (CIA) treatment device market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Chemotherapy induced alopecia (CIA) treatment device market revenues, 2023 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Chemotherapy induced alopecia (CIA) treatment device market Product outlook:
  • Fig. 14 Chemotherapy induced alopecia (CIA) treatment device market: Product movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global manual cooling systems market, 2018 - 2030 (USD Million)
  • Fig. 17 Global automated cooling systems market, 2018 - 2030 (USD Million)
  • Fig. 18 Chemotherapy induced alopecia (CIA) treatment device market Sales modality outlook:
  • Fig. 19 Chemotherapy induced alopecia (CIA) treatment device market: Sales modality movement analysis
  • Fig. 20 Global rental sales market, 2018 - 2030 (USD Million)
  • Fig. 21 Global direct sales market, 2018 - 2030 (USD Million)
  • Fig. 22 Chemotherapy induced alopecia (CIA) treatment device market Indication outlook:
  • Fig. 23 Chemotherapy induced alopecia (CIA) treatment device market: Indication movement analysis
  • Fig. 24 Global breast cancer market, 2018 - 2030 (USD Million)
  • Fig. 25 Global prostate cancer market, 2018 - 2030 (USD Million)
  • Fig. 26 Global ovarian cancer market, 2018 - 2030 (USD Million)
  • Fig. 27 Global uterine cancer market, 2018 - 2030 (USD Million)
  • Fig. 28 Global others market, 2018 - 2030 (USD Million)
  • Fig. 29 Chemotherapy induced alopecia (CIA) treatment device market End Use outlook:
  • Fig. 30 Chemotherapy induced alopecia (CIA) treatment device market: End Use movement analysis
  • Fig. 31 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 32 Global cancer centers market, 2018 - 2030 (USD Million)
  • Fig. 33 Global outpatient clinics market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional market place: Key takeaways
  • Fig. 35 North America Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 41 UK Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 42 France Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 47 China Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 48 India Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 52 MEA Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 55 Market Participant Categorization
  • Fig. 56 Strategy mapping
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!